ClinicalTrials.Veeva

Menu

Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

J

Johannes Gutenberg University (JGU)

Status

Unknown

Conditions

Endoscopy

Treatments

Other: gastroscopy in transnasal techique

Study type

Interventional

Funder types

Other

Identifiers

NCT04734912
ETNE v1.0

Details and patient eligibility

About

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.

Full description

COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy through the patient's mouth is therefore considered a high-risk examination for the medical and nursing staff. Alternatively, gastroscopy can also be performed through the patient's nose. An advantage here is that the aerosol formation is naturally significantly reduced and the patient usually does not need sedation, since in transnasal endoscopy no stranglehold occurs. Transnasal endoscopy therefore appears to us, especially during the COVID-19 pandemic, as a safe alternative to conventional gastroscopy.

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is sumbitted to the patient.

Only patients who have the indication for gastroscopy in transnasal technique are included. A specific risk to patients cannot be foreseen.This study does not interfere with diagnostics or therapy.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Indication for transnasal endoscopy

Exclusion criteria

  • pregnancy
  • breast feeding
  • contraindication to transnasal endoscopy
  • pronounced blood clotting disorders

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

500 participants in 1 patient group

Gastroscopy in transnasal technique
Other group
Description:
All patients with indication for gastroscopy in transnasal techqiue are included.
Treatment:
Other: gastroscopy in transnasal techique

Trial contacts and locations

1

Loading...

Central trial contact

Tanja Bender, M.A.; Helmut Neumann, M.D. PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems